Stuff needed to know for MPJE Flashcards
Acetaminophen with greater than 1gm/package
Child resistant packaging
Aspirin
Child resistant Packaging except for powder
Ibuprofen with greater than 1 gram/package
Child resistant packaging
Naproxen with greater than 250 mg/package
Child Resistant Packaging
Ketoprofen with greater than 50 mg/package
Child Resistant Packaging
Iron with greater than 250 mg of elemental iron per package
Child Resistant Packaging
Diphenhydramine with greater than 66 mg/package
Child resistant Packaging
Loperamide
Child resistant packaging
Minodoxil topcial
Child resistant packaging
Any previous products that were originally Rx only (PPIs)
Child resistant Packaging
SL nitroglycerin or SL and chewable isosorbide dinitrate
Does not require child resistant packaging
OC, Conjugated estrogens, Norethindrone, HRT
Does not require Child resistant packaging
Methylprednisolone with less than 84mg/package
Does not require child resistant packaging
Prednisone tablets with less than 105 mg/package
does not require child resistant packaging
Cholestyramine Powder
Does not require child resistant packaging
Unit dose potassium with less than 50 mEq per package
Does not require child resistant packaging
Erythromycin Ethylsuccinate granules (<8,8,16)
Does not require child resistant packaging
Fluoride liquid or tablets with less than 110 mg/package
Does not require child resistant packaging
Pancrealipase tablets, caps or powder
Does not require Child resistant packaging
Sudafed Base material
24.6 mg per 30 mg of Sudafed
Mebendazole Tablet with less than 600mg/package
Does not require child resistant packaging
Obra 90
Requiring pharmacists to preform DUR and counseling for all medicaid patients before dispensing to patient.
Antineoplastic drugs
NIOSH
Misoprostol
NIOSH
Chloramphenicol
NIOSH
Warfarin
NIOSH
Fluconazole, Voriconazole
NIOSH
Abacavir, Entecavir, Nevirapine, Zidovuidine
NIOSH
Cidofovir, Gancilovir, Valganciclovir
NIOSH
Isotretinoin
NIOSH
Dronedarone
NIOSH
Acitretin, Azathioprine, Leflunomide, Teriflunomide
NIOSH
Fingolimod
NIOSH
Dutasteride, Finasteride
NIOSH
Zoledronic Acid, Pamidronate
NIOSH
Paroxetine
NIOSH
Exenatide, Liragludie
NIOSH
Lomitapide
NIOSH
Colchicine
NIOSH
Ivabradine, Spironolactone
NIOSH
Ribavirin
NIOSH
Androgens, Estrogens, Progesterones, SERMS, Ulipristal
NIOSH
Methimazole, Propylthiouracil
NIOSH
Temazepam, Triazolam
NIOSH
Dihydroergotamine
NIOSH
Apomorphine, Rasagline
NIOSH
Ambrisetan, Bosentan, Macitentan, Riociguat
NIOSH
Ziprasidone
NIOSH
Cyclosporine, Mycophenolate, Tacrolimus, Sirolimus
NIOSH
Clobazam, Clonazepam
NIOSH
Carbamazepine, Oxcarbazepine, Zonisadmide
NIOSH
Phenytoin, Topiramate, Vigabatrin
NIOSH
Fosphenytoin, Divalproex, Eslicarbazepine
NIOSH
Step 1 of CSOS order and Supply chain
Pharmacy/purchaser submits enrollment to DEA
Step 2 of CSOS order and Supply chain
Pharmacy/purhcaser digitally scans order signed and sent to wholesaler/supplier
Step 3 CSOS order and Supply chain
Wholesaler/Purchaser validates certification through DEA of Pharmacy/Purchaser
Step 4 CSOS order and Supply chain
Wholesaler/Supplier supplies controlled substances to Pharmacy/Purchaser
Step 5 CSOS order and supply chain
Wholesaler/Supplier reports transaction to DEA
Calcium warning Statement for OTCs
Greater than 3.2 g
Magnesium warning statement for OTCs
Greater than 600 mg
Potassium warning statement for OTCs
greater than 975 mg
Sodium warning statement for OTC’s
greater than 140 mg but have different categories
less than or equal to 5 mg is considered sodium free
Very low sodium is less than or equal to 35 mg
Low sodium is less than or equal to 140mg
Pharmacy Orders controls from a supplier
Brown to Supplier
Green to DEA
Blue to Pharmacy
Pharmacy Returns controls to supplier
Brown to Pharmacy
Green to DEA
Blue to Supplier
Pharmacy sends unused drugs back to reverse distributor for disposal
Brown to Pharmacy
Green to DEA
Blue to Reverse Distributor
Pharmacy sells or lends drugs to another pharmacy
Brown to supplying pharmacy
Green to DEA
Blue to Receiving pharmacy
Pharmacy sells or lends drugs to physician for admin or dispensing
Brown to Pharmacy
Green to DEA
Blue to Physician
Info regarding Therapeutic Equivalence
To be therapeutically equivalent, the drug must be studied in vitro to determine it to be therapeutically equivalent and must meet rating in order for it to be equivalent.
Ex: AB1 to AB1 or AB1 AB2 to AB2 are considered equivalent
Ex: AB1 to AB2 are not considered equivalent